dexfenfluramine has been researched along with Chronic Disease in 5 studies
*Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodjian, S; Brune, M; Bush, E; Collins, CA; Dayton, B; Gao, J; Hernandez, LE; Judd, AS; Kym, PR; Marsh, KC; Mulhern, M; Sham, HL; Shapiro, R; Souers, AJ; Vasudevan, A; Wodka, D | 1 |
| Fotiou, F; Fountoulakis, KN; Iacovides, A; Kaprinis, G; Kaprinis, S | 1 |
| Antier, D; Bonnet, P; Eder, V; Hanton, G; Hyvelin, JM; Lemaire, MC; Rochefort, GY | 1 |
| Fotiou, F; Fountoulakis, KN; Gerasimou, G; Grammatikos, P; Iacovides, A; Kaprinis, G; Karamouzis, M | 1 |
| Ballmer, PE; Imoberdorf, R | 1 |
1 review(s) available for dexfenfluramine and Chronic Disease
| Article | Year |
|---|---|
[Obesity: principles of drug therapy].
Topics: Aminorex; Anti-Obesity Agents; Appetite Depressants; Chronic Disease; Combined Modality Therapy; Cyclobutanes; Dexfenfluramine; Diet, Reducing; Drug and Narcotic Control; Germany; Heart Valve Diseases; Humans; Hypertension, Pulmonary; Lactones; Obesity; Orlistat; Phentermine | 2000 |
1 trial(s) available for dexfenfluramine and Chronic Disease
| Article | Year |
|---|---|
Biological markers and psychophysiological methods as long term response predictors to fluoxetine treatment.
Topics: Adrenal Cortex Hormones; Adult; Chronic Disease; Depression; Dexamethasone; Dexfenfluramine; Drug Administration Schedule; Female; Fluoxetine; Follow-Up Studies; Humans; Prolactin; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists | 2004 |
3 other study(ies) available for dexfenfluramine and Chronic Disease
| Article | Year |
|---|---|
Identification of 2-(4-benzyloxyphenyl)-N- [1-(2-pyrrolidin-1-yl-ethyl)-1H-indazol-6-yl]acetamide, an orally efficacious melanin-concentrating hormone receptor 1 antagonist for the treatment of obesity.
Topics: Acetamides; Administration, Oral; Animals; Anti-Obesity Agents; Binding, Competitive; Brain; Calcium; Chronic Disease; Indazoles; Mice; Obesity; Pyrrolidines; Radioligand Assay; Receptors, Somatostatin; Structure-Activity Relationship; Tissue Distribution | 2005 |
Dexfenfluramine does not worsen but moderates progression of chronic hypoxia-induced pulmonary hypertension.
Topics: Animals; Blood Pressure; Body Weight; Chronic Disease; Dexfenfluramine; Disease Progression; Female; Heart Valve Diseases; Hypertension, Pulmonary; Hypoxia; Lung; Myocardium; Organ Size; Rats; Rats, Wistar; Serotonin Receptor Agonists; Ultrasonography, Doppler; Ventricular Function, Left; Ventricular Function, Right; Weight Gain | 2006 |
Is it possible to predict the long-term response to venlafaxine with the use of biological markers and psychophysiological methods?
Topics: Adult; Antidepressive Agents; Brain; Chronic Disease; Cyclohexanols; Depressive Disorder, Major; Dexamethasone; Dexfenfluramine; Dominance, Cerebral; Electrooculography; Electroretinography; Evoked Potentials, Visual; Female; Follow-Up Studies; Globus Pallidus; Humans; Hydrocortisone; Male; Middle Aged; Prognosis; Prolactin; Recurrence; Regional Blood Flow; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |